Copyright
©The Author(s) 2019.
World J Gastroenterol. Feb 28, 2019; 25(8): 955-966
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.955
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.955
Figure 3 Effects of procyanidin B2 on hepatic steatosis.
A: Hematoxylin and eosin staining of liver in CHOW group, HCD group and procyanidin B2 group; B: Liver weight; C: Alanine transaminase; D: Aspartate transaminase; E: Relative expression levels of steroid response element binding protein 1c; F: Relative expression levels of fatty acid synthase; G: Relative expression levels of carnitine palmitoyltransferase. The data are expressed as means ± SD. aP < 0.05 vs CHOW group; bP < 0.05 vs HCD group. HCD: High-fat-cholesterol diet; PB2: Procyanidin B2; ALT: Alanine transaminase; AST: Aspartate transaminase; SREBP-1c: Steroid response element binding protein 1c; FASN: Fatty acid synthase; CPT: Carnitine palmitoyltransferase; SD: Standard deviation.
- Citation: Xing YW, Lei GT, Wu QH, Jiang Y, Huang MX. Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits. World J Gastroenterol 2019; 25(8): 955-966
- URL: https://www.wjgnet.com/1007-9327/full/v25/i8/955.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i8.955